Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03610165 · ClinicalTrials.gov registry record · NA
Hypotension Prediction Index for Blood Pressure Management
A NA study of Intraoperative Hypotension, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 214
- Enrollment target
- 1
- Study location
NCT03610165: Completed NA study of Intraoperative Hypotension, sponsored by The Cleveland Clinic.
NCT03610165 is a NA study of Intraoperative Hypotension that has completed, run by The Cleveland Clinic. The registered enrollment target is 214 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03610165, a NA study of Intraoperative Hypotension, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 214 participants
- Enrollment target
- 1
- Study location
Study Summary
Design: Single-center randomized comparison of invasive arterial pressure monitoring vs. arterial pressure monitoring combined with Acumen Hypotension Prediction Index (HPI) software guidance on intraoperative hypotension duration and severity. Aim: To determine whether use of Acumen HPI software guidance to guide intraoperative hemodynamic management in the non-cardiac surgery reduces the duration and severity of hypotension. Primary hypothesis: Our primary hypothesis is that adding Acumen HPI software guidance to the information provided by the invasive arterial pressure monitoring during moderate- to high-risk noncardiac surgery reduces time-weighted average (TWA) intraoperative hypotension below a threshold of 65 mmHg.
Primary Outcome
MAP stands for mean arterial pressure. Time-weighted average MAP below 65 mmHg threshold for each patient was derived by dividing AUC-MAP by the time interval between the first and the last MAP measurements.
Conditions Studied
Interventions
- DEVICE Control
- DEVICE Acumen HPI-enabled EV1000 screen
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
What the finished NCT03610165 record still lists
NCT03610165 is an interventional study that assigns participants to a tested intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Intraoperative Hypotension appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT03610165 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03610165 about?
NCT03610165 is a clinical study titled "Hypotension Prediction Index for Blood Pressure Management". Design: Single-center randomized comparison of invasive arterial pressure monitoring vs. arterial pressure monitoring combined with Acumen Hypotension Prediction Index (HPI) software guidance on intraoperative hypotension duration and severity. Aim: To determine whether use of Acumen HPI software g...
What is the current status of trial NCT03610165?
This trial is currently completed. It is a NA study. The enrollment target is 214 participants. The study started on 2018-07-12. Estimated completion is 2021-03-31.
What conditions does trial NCT03610165 study?
This clinical trial studies the following conditions: Intraoperative Hypotension.
What interventions are being tested in trial NCT03610165?
The interventions under investigation include: Control (DEVICE), Acumen HPI-enabled EV1000 screen (DEVICE).
Who is sponsoring clinical trial NCT03610165?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03610165 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intraoperative Hypotension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03610165's enrollment target sits among peer trials
214 487th of 2000 higher than 1,513 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- NCT04667520 · 214 participants · NA
Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment
- NCT05418868 · 214 participants · Phase 1
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI